DAMBKOWSKI CARL (Chief Medical Officer) sold 2.5% of their position (5.50K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $361.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+4.13K
Price / share
$22.86
Trade value
$94.30K
% of position
Common Stock
Shares
−2.48K
Price / share
$64.88
Trade value
$160.97K
% of position
Common Stock
Shares
−1.42K
Price / share
$65.83
Trade value
$93.48K
% of position
Common Stock
Shares
−1.30K
Price / share
$66.85
Trade value
$86.84K
% of position
Common Stock
Shares
−100.00
Price / share
$67.88
Trade value
$6.79K
% of position
Common Stock
Shares
−200.00
Price / share
$68.94
Trade value
$13.79K
% of position
Net shares
−1.38K
Net value
-$267.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | M · Option Exercise | +4.13K | $22.86 | $94.30K | 1.9% | 212.52K | 216.65K |
| Common Stock Direct | 2/4/2026 | S · Sale | −2.48K | $64.88 | $160.97K | 1.1% | 216.65K | 214.17K |
| Common Stock Direct | 2/4/2026 | S · Sale | −1.42K | $65.83 | $93.48K | 0.7% | 214.17K | 212.75K |
| Common Stock Direct | 2/4/2026 | S · Sale | −1.30K | $66.85 | $86.84K | 0.6% | 212.75K | 211.45K |
| Common Stock Direct | 2/4/2026 | S · Sale | −100.00 | $67.88 | $6.79K | 0.0% | 211.45K | 211.35K |
| Common Stock Direct | 2/4/2026 | S · Sale | −200.00 | $68.94 | $13.79K | 0.1% | 211.35K | 211.15K |
| Total | −1.38K | -$267.56K | ||||||
Stock Option (Right to Buy)
Common Stock
4.13K shares
Shares
−4.13K
Strike price
22.86
Held after
135.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.13K shares | 2/4/2026 | M · Option Exercise | −4.13K | 22.86 | — | 135.41K |